Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Lantheus ( (LNTH) ) is now available.
Jeff Humphrey, MD, will no longer serve as Chief Medical Officer at Lantheus Holdings, Inc., with his last day being January 3, 2025. His departure is amicable and not due to any disagreements, and interim leadership of research and development will be handled by CEO Brian Markison and President Paul Blanchfield while a search for his replacement is conducted.
More about Lantheus
YTD Price Performance: 47.02%
Average Trading Volume: 995,222
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.34B
Learn more about LNTH stock on TipRanks’ Stock Analysis page.
